The Food and Drug Administration is imposing a clinical hold on several of Seattle Genetics’ early-stage studies involving an experimental cancer drug following the deaths of four people, Reuters ...
The Food and Drug Administration removed a clinical hold it placed on Seattle Genetics’ drug trial in December following the deaths of four patients, reports Reuters. During the trial for vadastuximab ...
This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. (AP Photo/Andrew Harnik, File) Seattle Genetics Inc. said four people had died in trials testing its ...
BOTHELL, Wash. (AP) - Biotechnology company Seattle Genetics Inc. said Thursday it will receive an $8 million fee from Pfizer Inc. for rights to use its cancer-fighting antibody-drug conjugate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback